We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current GTHX market cap is 195.75M. The company's latest EPS is USD -0.9189 and P/E is -4.10.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 23.58M | 10.25M | 12.95M | 42.39M | 12.3M |
| Operating Income | -21.55M | -30.89M | -25.75M | 12.61M | -16.37M |
| Net Income | -25.27M | -33.65M | -27.6M | 8.71M | -18.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 45.29M | 31.48M | 51.3M | 82.51M |
| Operating Income | -129.04M | -96.48M | -142.46M | -136.18M | -39.53M |
| Net Income | -122.45M | -99.25M | -148.35M | -147.56M | -47.97M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 166.57M | 187.97M | 161.96M | 147.89M | 133.1M |
| Total Liabilities | 120.61M | 119.22M | 116.97M | 90.34M | 90.08M |
| Total Equity | 45.97M | 68.75M | 44.99M | 57.55M | 43.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 284.83M | 228.55M | 254.09M | 187.97M | 121.54M |
| Total Liabilities | 29.3M | 51.2M | 110.55M | 119.22M | 86.15M |
| Total Equity | 255.53M | 177.35M | 143.54M | 68.75M | 35.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -97.99M | -128.62M | -29.05M | -14.97M | -25.55M |
| Investing | -30.17M | -50.53M | 2.91M | 3.26M | 10.46M |
| Financing | 145k | 52.5M | -214k | -26.97M | -26.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -99.57M | -83.74M | -132.11M | -128.62M | -38.34M |
| Investing | -2.72M | 152k | N/A | -50.53M | 2.81M |
| Financing | 2.71M | 21.69M | 145.86M | 52.5M | -26.91M |
| Market Cap | 195.75M |
| Price to Earnings Ratio | -4.10 |
| Price to Sales Ratio | 2.39 |
| Price to Cash Ratio | 6.11 |
| Price to Book Ratio | 5.56 |
| Dividend Yield | - |
| Shares Outstanding | 52.2M |
| Average Volume (1 week) | 433.37k |
| Average Volume (1 Month) | 692.81k |
| 52 Week Change | 29.31% |
| 52 Week High | 5.00 |
| 52 Week Low | 1.08 |
| Spread (Intraday) | 0.01 (0.27%) |
| Company Name | G1 Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.g1therapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
